CYBN
Cybin
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
CYBN Profile
Cybin Inc.
A biopharmaceutical company that developing psychedelic therapeutics for psychiatric disorders
Pharmaceutical
Invalid Date
08/05/2021
American Stock Exchange
50
03-31
Common stock
100 King Street West, Suite 5600, Toronto, Ontario, Canada M5X 1C9
--
Cybin Inc., was founded in 2019 in Ontario, Canada. The company operates in Canada, the United States, the United Kingdom and Ireland. The company focuses on developing psychedelics into therapies by designing patented drug discovery platforms, innovative drug delivery systems, novel formulation methods and treatment options for mental health disorders.